Remove Clinical Research Remove Document Remove FDA Compliance
article thumbnail

FDA End-of-Year Release of Warning Letters Impresses (or Depresses)

FDA Law Blog: Biosimilars

The FDA compliance data, sorted by category, shows there were 159 Warning Letters issued to drug manufacturers or sponsors during 2023, with 161 issued in calendar year 2022. FDA stated that the firm received 96 U.S. Finally, FDA said in a Warning Letter that a Clinical Investigator, Anish S. Terragene S.A.,

FDA 57